BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24418935)

  • 21. Multiple mucociliary transit marker tracking in synchrotron X-ray images using the global nearest neighbor method.
    Hye-Won Jung ; Lee I; Sang-Heon Lee ; Parsons D; Donnelley M
    Annu Int Conf IEEE Eng Med Biol Soc; 2017 Jul; 2017():1824-1827. PubMed ID: 29060244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001506. PubMed ID: 19370568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-time in vivo imaging of regional lung function in a mouse model of cystic fibrosis on a laboratory X-ray source.
    Murrie RP; Werdiger F; Donnelley M; Lin YW; Carnibella RP; Samarage CR; Pinar I; Preissner M; Wang J; Li J; Morgan KS; Parsons DW; Dubsky S; Fouras A
    Sci Rep; 2020 Jan; 10(1):447. PubMed ID: 31949224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synchrotron phase-contrast X-ray imaging reveals fluid dosing dynamics for gene transfer into mouse airways.
    Donnelley M; Siu KK; Jamison RA; Parsons DW
    Gene Ther; 2012 Jan; 19(1):8-14. PubMed ID: 21654825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of apical hyperosmotic sodium challenge and amiloride on sodium transport in human bronchial epithelial cells from cystic fibrosis donors.
    Rasgado-Flores H; Krishna Mandava V; Siman H; Van Driessche W; Pilewski JM; Randell SH; Bridges RJ
    Am J Physiol Cell Physiol; 2013 Dec; 305(11):C1114-22. PubMed ID: 23986197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Regnis JA; Wong AG; Bailey DL; Bautovich GJ; King M; Bye PT
    Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hypertonic saline, amiloride, and cough on mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Regnis JA; Bailey DL; King M; Bautovich GJ; Bye PT
    Am J Respir Crit Care Med; 1996 May; 153(5):1503-9. PubMed ID: 8630593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved in-vivo airway gene transfer via magnetic-guidance, with protocol development informed by synchrotron imaging.
    Donnelley M; Cmielewski P; Morgan K; Delhove J; Reyne N; McCarron A; Rout-Pitt N; Drysdale V; Carpentieri C; Spiers K; Takeuchi A; Uesugi K; Yagi N; Parsons D
    Sci Rep; 2022 May; 12(1):9000. PubMed ID: 35637239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo X-ray imaging reveals improved airway surface hydration after a therapy designed for cystic fibrosis.
    Morgan KS; Donnelley M; Farrow N; Fouras A; Yagi N; Suzuki Y; Takeuchi A; Uesugi K; Boucher RC; Siu KK; Parsons DW
    Am J Respir Crit Care Med; 2014 Aug; 190(4):469-71. PubMed ID: 25127306
    [No Abstract]   [Full Text] [Related]  

  • 30. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.
    Stahl M; Wielpütz MO; Ricklefs I; Dopfer C; Barth S; Schlegtendal A; Graeber SY; Sommerburg O; Diekmann G; Hüsing J; Koerner-Rettberg C; Nährlich L; Dittrich AM; Kopp MV; Mall MA
    Am J Respir Crit Care Med; 2019 May; 199(10):1238-1248. PubMed ID: 30409023
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration of action of hypertonic saline on mucociliary clearance in the normal lung.
    Bennett WD; Wu J; Fuller F; Balcazar JR; Zeman KL; Duckworth H; Donn KH; O'Riordan TG; Boucher RC; Donaldson SH
    J Appl Physiol (1985); 2015 Jun; 118(12):1483-90. PubMed ID: 25911685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V; Jones AP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
    Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ
    BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway-rehydrating agents for the treatment of cystic fibrosis: past, present, and future.
    Pettit RS; Johnson CE
    Ann Pharmacother; 2011 Jan; 45(1):49-59. PubMed ID: 21156814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety.
    Rosenfeld M; Davis S; Brumback L; Daniel S; Rowbotham R; Johnson R; McNamara S; Jensen R; Barlow C; Ratjen F
    Pediatr Pulmonol; 2011 Jul; 46(7):666-71. PubMed ID: 21365779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.
    Reeves EP; Molloy K; Pohl K; McElvaney NG
    ScientificWorldJournal; 2012; 2012():465230. PubMed ID: 22645424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
    JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative imaging of airway liquid absorption in cystic fibrosis.
    Locke LW; Myerburg MM; Markovetz MR; Parker RS; Weber L; Czachowski MR; Harding TJ; Brown SL; Nero JA; Pilewski JM; Corcoran TE
    Eur Respir J; 2014 Sep; 44(3):675-84. PubMed ID: 24743971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.